Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04585191 · ClinicalTrials.gov registry record · NA

Reducing Treatment Risk in Older Adults With Diabetes

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
450
Enrollment target

NCT04585191 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 450 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04585191, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
450 participants
Enrollment target

Study Summary

This study will evaluate the impact of academic detailing (evidence-based provider education) with or without patient pre-visit preparation (elicitation of values and preferences) on safe insulin de-prescribing among older patients with type 2 diabetes at risk for hypoglycemia. The hypothesis is that patients who are well-prepared for their primary care visit will engage in more informed discussions with their providers regarding re-evaluation of current treatment regimens. In clinically appropriate cases, these more effective discussions will result in safe de-prescribing and fewer future episodes of hypoglycemia.

Interventions

  • BEHAVIORAL Conversation Aid
  • OTHER Attention Control Educational Handout

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2020-11-02
Est. Completion 2024-09-01
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT04585191

The ClinicalTrials.gov registry entry for NCT04585191 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Conversation Aid is the first listed.

NCT04585191 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04585191 about?

NCT04585191 is a clinical study titled "Reducing Treatment Risk in Older Adults With Diabetes". This study will evaluate the impact of academic detailing (evidence-based provider education) with or without patient pre-visit preparation (elicitation of values and preferences) on safe insulin de-prescribing among older patients with type 2 diabetes at risk for hypoglycemia. The hypothesis is tha...

What is the current status of trial NCT04585191?

This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2020-11-02. Estimated completion is 2024-09-01.

What interventions are being tested in trial NCT04585191?

The interventions under investigation include: Conversation Aid (BEHAVIORAL), Attention Control Educational Handout (OTHER).

Who is sponsoring clinical trial NCT04585191?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.